About Us

We are an innovative company developing RNA-targeted therapeutics focussed to improve the quality of life for people with rare and age related medical conditions.

Sutura Therapeutics has developed proprietary RNA-targeting gene therapeutics and seeks to provide novel treatment regimens for medical conditions with unmet clinical needs. The platform technology has extremely broad clinical applications that can have a profound societal impact. 

FIND OUT MORE

Pipelines

Our first pipeline development focusses on addressing the spectrum of pathological changes initially in Duchenne muscular dystrophy with further pipelines in advanced developed to include additional rare and age related medical conditions.

FIND OUT MORE

Get in touch

General Enquiries

info@suturatherapeutics.com
+44 (0) 7881 955 716

Biotech & Partnerships

partners@suturatherapeutics.com
+44 (0) 7881 955 716

Investors

investors@suturatherapeutics.com
+44 (0) 7881 955 716

Keep Informed

Sign up for future updates

Thank you